LUMEA Inc., previously known as Leavitt Medical, is dedicated to revolutionizing cancer diagnostics. Its team developed a biopsy-to-digital diagnostic platform that modernizes pathology, making diagnosis more reliable.
The current practices for pathologists handling and preparing biopsies for diagnosis are inefficient, costly and have varying levels of quality standards. To solve this problem, LUMEA invented the BxChipâ„¢, BxLinkâ„¢, and DxLogic and is always in the process of testing and inventing more tools to help the modern pathologist. Learn about how each of these tools reinvents pathology at LUMEA.org.
LUMEA was founded by Dr. Matthew Leavitt, a Stanford-trained pathologist who has dedicated his career to changing and improving cancer diagnostics. Its experienced employees all work together to save lives by revolutionizing diagnostic medicine.